This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Background: Increased hypothalamic–pituitary–adrenal (HPA) axis activity manifested by elevated cortisol levels is observed in AD and may contribute to AD by lowering the threshold for neuronal degeneration. Presence of the APOE-ε4 allele increases risk for AD. Increased cortisol concentrations in apoE-deficient mice suggest that APOE genotype may influence cortisol concentrations in AD.
Methods: The authors measured cortisol levels in CSF and determined APOE genotypes for 64 subjects with AD and 34 nondemented older control subjects.
Results: CSF cortisol was significantly higher in AD than in control subjects. CSF cortisol concentrations differed with respect to APOE genotype in both subjects with AD (ε4/ε4 > ε3/4ε > ε3/ε3) and normal older control subjects (ε3/ε4 > ε3/ε3 > ε2/ε3). Comparison of CSF cortisol concentrations within the ε3/ε4 and ε3/ε3 genotypes revealed no differences between AD and control subject groups.
Conclusions: Higher CSF cortisol concentrations were associated with increased frequency of the APOE-ε4 allele and decreased frequency of the APOE-ε2 allele in AD subjects relative to control subjects. This effect of APOE genotype on HPA axis activity may be related to the increased risk for AD in persons carrying the APOE-ε4 allele and decreased risk for AD in persons carrying the APOE-ε2 allele.
- Received August 14, 2000.
- Accepted January 6, 2001.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
- Reply to Sass et al
- Increased CSF cortisol in AD is a function of APOE genotype
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Alert Me
Recommended articles
Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis
Circulating cortisol and cognitive and structural brain measures
APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD
APOE genotype modulates the effect of serum calcium levels on cognitive function in old age